Insights

Expanding Therapeutic Pipeline Angelini Pharma is actively investing in the development of innovative treatments, including their latest SVG105 for brain health disorders, highlighting opportunities to collaborate on novel CNS and mental health solutions.

Strategic Partnerships The company's recent licensing deals, such as with GRIN Therapeutics, demonstrate a strong focus on forming strategic alliances, presenting opportunities to explore joint ventures or co-development partnerships.

Market Focus on CNS & Mental Health With a pledge to lead in CNS and mental health disorders, Angelini Pharma is a key player for specialized product supply, providing potential for targeted sales of therapeutic drugs and related healthcare solutions.

Global Asset Management Recent assets sales and repositioning efforts indicate active portfolio management, offering avenues for procurement of innovative assets or involvement in asset repositioning projects.

Recognition & Market Presence Multiple awards and active participation in major congresses such as EAN and European Epilepsy Congress underline its industry credibility, making it an ideal partner for outreach in neurological and mental health markets.

Angelini Pharma Tech Stack

Angelini Pharma uses 8 technology products and services including Open Graph, OWL Carousel, Modernizr, and more. Explore Angelini Pharma's tech stack below.

  • Open Graph
    Content Management System
  • OWL Carousel
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • Priority Hints
    Performance
  • Java
    Programming Languages
  • Google Analytics
    Web Analytics
  • Magnific Popup
    Web Tools And Plugins

Media & News

Angelini Pharma's Email Address Formats

Angelini Pharma uses at least 1 format(s):
Angelini Pharma Email FormatsExamplePercentage
First.Last@angelinipharma.comJohn.Doe@angelinipharma.com
98%
First.Middle@angelinipharma.comJohn.Michael@angelinipharma.com
1%
Last.First@angelinipharma.comDoe.John@angelinipharma.com
1%

Frequently Asked Questions

Where is Angelini Pharma's headquarters located?

Minus sign iconPlus sign icon
Angelini Pharma's main headquarters is located at 70 Viale Amelia Roma, Lazio 00181 Italy. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Angelini Pharma's official website and social media links?

Minus sign iconPlus sign icon
Angelini Pharma's official website is angelinipharma.com and has social profiles on LinkedInCrunchbase.

How much revenue does Angelini Pharma generate?

Minus sign iconPlus sign icon
As of February 2026, Angelini Pharma's annual revenue is estimated to be $890M.

What is Angelini Pharma's NAICS code?

Minus sign iconPlus sign icon
Angelini Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Angelini Pharma have currently?

Minus sign iconPlus sign icon
As of February 2026, Angelini Pharma has approximately 2K employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Scientific Officer, Global R&d Head, Executive Committee Member: R. K.Chief Medical Officer: A. C.Chief Business Development Officer: A. M.. Explore Angelini Pharma's employee directory with LeadIQ.

What industry does Angelini Pharma belong to?

Minus sign iconPlus sign icon
Angelini Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Angelini Pharma use?

Minus sign iconPlus sign icon
Angelini Pharma's tech stack includes Open GraphOWL CarouselModernizrSalesforce Marketing Cloud Account EngagementPriority HintsJavaGoogle AnalyticsMagnific Popup.

What is Angelini Pharma's email format?

Minus sign iconPlus sign icon
Angelini Pharma's email format typically follows the pattern of First.Last@angelinipharma.com. Find more Angelini Pharma email formats with LeadIQ.

How much funding has Angelini Pharma raised to date?

Minus sign iconPlus sign icon
As of February 2026, Angelini Pharma has raised $1.7M in funding. The last funding round occurred on Jul 13, 2023 for $1.7M.

Angelini Pharma

Pharmaceutical ManufacturingLazio, Italy1001-5000 Employees

At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. Since 1919. 
We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. 
We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies.
We pledge to successfully develop distinctive treatments for CNS and Mental Health disorders while preserving our leading position in the Consumer Health segment.
Angelini Pharma is part of Angelini Industries.

Social media privacy notice: https://bit.ly/socialmediaprivacynotice

Section iconCompany Overview

Headquarters
70 Viale Amelia Roma, Lazio 00181 Italy
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1.7M

    Angelini Pharma has raised a total of $1.7M of funding over 1 rounds. Their latest funding round was raised on Jul 13, 2023 in the amount of $1.7M.

  • $1B$10B

    Angelini Pharma's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1.7M

    Angelini Pharma has raised a total of $1.7M of funding over 1 rounds. Their latest funding round was raised on Jul 13, 2023 in the amount of $1.7M.

  • $1B$10B

    Angelini Pharma's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.